CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 39 enrolled
Drug / intervention
Moderate intensity walking or steppingbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06125704
NCT06125704N/ACompleted

The Time to Move Randomized Crossover Trial

The University of Tennessee, Knoxville·interventional·Posted Nov 9, 2023·Updated Apr 29, 2026

In Brief

A clinical study evaluating Moderate intensity walking or stepping for GDM and 5 related conditions. Completed, enrolled 39 participants across 1 site.

Detailed Summary

This randomized controlled crossover trial of 36 pregnant individuals with gestational diabetes (GDM) or gestational glucose intolerance (GGI) will: 1. Determine the effects of physical activity (PA) timing, specifically 30 minutes of moderate intensity walking or stepping in the morning (between 5am-9am, within 30-40 minutes of starting breakfast), versus late afternoon/evening (between 4pm-8pm, within 30-40 minutes of dinner) on glucose across the 24-hour cycle. 2. Explore the potential effects of the timing of PA on sleep and mood state.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
202420252026
First PostedNov 9, 2023
Enrollment StartDec 6, 2023
Primary CompletionNov 24, 2025
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 2.6 years ago

Interventions

Moderate intensity walking or steppingbehavioral

30 minutes of moderate intensity walking or stepping (i.e., at a pace of approximately 100 steps per minute), varied by time of day it is performed: morning (i.e., between 5am-9am, within 30-40 minutes of starting breakfast) versus late afternoon/evening (i.e., between 4pm-8pm, within 30-40 minutes of dinner).